Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors.
PIK3CA, the gene coding for the p110α subunit of phosphoinositide 3-kinase, is frequently mutated in a variety of human tumors including breast cancers. To better understand the role of mutant PIK3CA in the initiation and/or progression of breast cancer, we have generated mice with a conditional kno...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/79b86ce44cd14ab4b50082986f282edd |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:79b86ce44cd14ab4b50082986f282edd |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:79b86ce44cd14ab4b50082986f282edd2021-11-18T07:16:59ZPhysiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors.1932-620310.1371/journal.pone.0036924https://doaj.org/article/79b86ce44cd14ab4b50082986f282edd2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22666336/?tool=EBIhttps://doaj.org/toc/1932-6203PIK3CA, the gene coding for the p110α subunit of phosphoinositide 3-kinase, is frequently mutated in a variety of human tumors including breast cancers. To better understand the role of mutant PIK3CA in the initiation and/or progression of breast cancer, we have generated mice with a conditional knock-in of the common activating mutation, Pik3ca(H1047R), into one allele of the endogenous gene in the mammary gland. These mice developed a ductal anaplasia and hyperplasia by 6 weeks of age characterized by multi-layering of the epithelial lining of the mammary ducts and expansion of the luminal progenitor (Lin(-); CD29(lo); CD24(+); CD61(+)) cell population. The Pik3ca(H1047R) expressing mice eventually develop mammary tumors with 100% penetrance but with a long latency (>12 months). This is significantly longer than has been reported for transgenic models where expression of the mutant Pik3ca is driven by an exogenous promoter. Histological analysis of the tumors formed revealed predominantly ERα-positive fibroadenomas, carcinosarcomas and sarcomas. In vitro induction of Pik3ca(H1047R) in immortalized mammary epithelial cells also resulted in tumor formation when injected into the mammary fat pad of immunodeficient recipient mice. This novel model, which reproduces the scenario of a heterozygous somatic mutation occurring in the endogenous PIK3CA gene, will thus be a valuable tool for investigating the role of Pik3ca(H1047R) mutation in mammary tumorigenesis both in vivo and in vitro.Anjali TikooVincent RohKaren G MontgomeryIvan IvetacPaul WaringRebecca PelzerLauren HareMark ShackletonPatrick HumbertWayne A PhillipsPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 5, p e36924 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Anjali Tikoo Vincent Roh Karen G Montgomery Ivan Ivetac Paul Waring Rebecca Pelzer Lauren Hare Mark Shackleton Patrick Humbert Wayne A Phillips Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors. |
| description |
PIK3CA, the gene coding for the p110α subunit of phosphoinositide 3-kinase, is frequently mutated in a variety of human tumors including breast cancers. To better understand the role of mutant PIK3CA in the initiation and/or progression of breast cancer, we have generated mice with a conditional knock-in of the common activating mutation, Pik3ca(H1047R), into one allele of the endogenous gene in the mammary gland. These mice developed a ductal anaplasia and hyperplasia by 6 weeks of age characterized by multi-layering of the epithelial lining of the mammary ducts and expansion of the luminal progenitor (Lin(-); CD29(lo); CD24(+); CD61(+)) cell population. The Pik3ca(H1047R) expressing mice eventually develop mammary tumors with 100% penetrance but with a long latency (>12 months). This is significantly longer than has been reported for transgenic models where expression of the mutant Pik3ca is driven by an exogenous promoter. Histological analysis of the tumors formed revealed predominantly ERα-positive fibroadenomas, carcinosarcomas and sarcomas. In vitro induction of Pik3ca(H1047R) in immortalized mammary epithelial cells also resulted in tumor formation when injected into the mammary fat pad of immunodeficient recipient mice. This novel model, which reproduces the scenario of a heterozygous somatic mutation occurring in the endogenous PIK3CA gene, will thus be a valuable tool for investigating the role of Pik3ca(H1047R) mutation in mammary tumorigenesis both in vivo and in vitro. |
| format |
article |
| author |
Anjali Tikoo Vincent Roh Karen G Montgomery Ivan Ivetac Paul Waring Rebecca Pelzer Lauren Hare Mark Shackleton Patrick Humbert Wayne A Phillips |
| author_facet |
Anjali Tikoo Vincent Roh Karen G Montgomery Ivan Ivetac Paul Waring Rebecca Pelzer Lauren Hare Mark Shackleton Patrick Humbert Wayne A Phillips |
| author_sort |
Anjali Tikoo |
| title |
Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors. |
| title_short |
Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors. |
| title_full |
Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors. |
| title_fullStr |
Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors. |
| title_full_unstemmed |
Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors. |
| title_sort |
physiological levels of pik3ca(h1047r) mutation in the mouse mammary gland results in ductal hyperplasia and formation of erα-positive tumors. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2012 |
| url |
https://doaj.org/article/79b86ce44cd14ab4b50082986f282edd |
| work_keys_str_mv |
AT anjalitikoo physiologicallevelsofpik3cah1047rmutationinthemousemammaryglandresultsinductalhyperplasiaandformationoferapositivetumors AT vincentroh physiologicallevelsofpik3cah1047rmutationinthemousemammaryglandresultsinductalhyperplasiaandformationoferapositivetumors AT karengmontgomery physiologicallevelsofpik3cah1047rmutationinthemousemammaryglandresultsinductalhyperplasiaandformationoferapositivetumors AT ivanivetac physiologicallevelsofpik3cah1047rmutationinthemousemammaryglandresultsinductalhyperplasiaandformationoferapositivetumors AT paulwaring physiologicallevelsofpik3cah1047rmutationinthemousemammaryglandresultsinductalhyperplasiaandformationoferapositivetumors AT rebeccapelzer physiologicallevelsofpik3cah1047rmutationinthemousemammaryglandresultsinductalhyperplasiaandformationoferapositivetumors AT laurenhare physiologicallevelsofpik3cah1047rmutationinthemousemammaryglandresultsinductalhyperplasiaandformationoferapositivetumors AT markshackleton physiologicallevelsofpik3cah1047rmutationinthemousemammaryglandresultsinductalhyperplasiaandformationoferapositivetumors AT patrickhumbert physiologicallevelsofpik3cah1047rmutationinthemousemammaryglandresultsinductalhyperplasiaandformationoferapositivetumors AT wayneaphillips physiologicallevelsofpik3cah1047rmutationinthemousemammaryglandresultsinductalhyperplasiaandformationoferapositivetumors |
| _version_ |
1718423673663127552 |